H.B. Fuller Announces AMS Shareholders Approve Proposed Acquisition
H.B. Fuller Company the world’s largest pureplay adhesives company, today announced that shareholders of Advanced Medical Solutions Group plc (“AMS”) (LSE:AMS) approved H.B. Fuller’s proposed acquisition of AMS at specially convened meetings of AMS shareholders held on August 12, 2026.
We are pleased with this significant milestone,” said Celeste Mastin, president and chief executive officer of H.B. Fuller. “AMS is an exceptional company and a rare strategic fit that advances our vision for the future of H.B. Fuller. By combining AMS’s leading medical technologies, innovation expertise, and regulatory capabilities with H.B. Fuller’s global scale and commercial reach, we will create a differentiated healthcare platform positioned for faster growth, stronger margins, and greater value creation. We are excited to welcome the AMS team and begin the next chapter together.
The approval of AMS shareholders represents a significant milestone towards completion of the transaction and follows the agreement on the terms of a recommended cash acquisition previously announced by the companies on June 25, 2026. The transaction is expected to close by the end of the calendar year, subject to satisfaction or waiver of the remaining conditions set forth in the transaction documents.
About H.B. Fuller
As the largest pureplay adhesives company in the world, H.B. Fuller’s (NYSE: FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2025 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,100 global team members who collaborate with customers across more than 30 market segments in 150 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets.
